SPAIN - Vista acquires pharma business for EUR 360m
Vista Capital has wholly purchased pharmaceutical business Laboratorios Indas from the Arochena family for around EUR 360m. It is understood that the private equity firm has faced competition from its peers Mercapital, Nmás1 and Ibersuizas, before signing an exclusivity agreement with the company’s owners in early February.
More on Buyouts
SGT Capital to acquire Summit-backed Elatec for EUR 400m
Mid-market sponsor looks to grow company via “continued technical innovation” and international expansion
Egeria to exit GoodLife Foods in SBO to IK Partners
Acquisition of Dutch frozen snack maker marks 13th investment from IK IX Fund
Permira to acquire majority stake in Gruppo Florence
Existing shareholders including VAM Investments and management of the Italian fashion group will reinvest, while Italmobiliare will exit
Gyrus Capital acquires LRE Medical from KPS-backed AIS Global
Carve-out of German diagnostic equipment manufacturer comes over two years after first sale attempt
Latest News
Bewater Funds nears EUR 7m close for second fund, aims to back 20 companies in next four years
Bewater II FCRE takes minority stakes (5%-25%) with tickets of EUR 500,000-EUR 2m, and it has already made three investments.
Unquote Private Equity Podcast: In conversation with... Fabio Ranghino, Ambienta
In an interview with Unquote, Ranghino discusses topics including ESG and the next phase of Ambienta’s growth
Qualium closes third flagship fund on more than EUR 500m
French mid-cap GP began marketing the fund in summer 2021; it has deployed EUR 220m to date
SGT Capital to acquire Summit-backed Elatec for EUR 400m
Mid-market sponsor looks to grow company via “continued technical innovation” and international expansion